DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,146 | +19.5% | 77,545 | +4.5% | 0.00% | – |
Q2 2023 | $959 | +41.7% | 74,212 | +7.6% | 0.00% | – |
Q1 2023 | $677 | -4.6% | 68,946 | +3.3% | 0.00% | – |
Q4 2022 | $710 | -99.9% | 66,744 | -8.9% | 0.00% | – |
Q3 2022 | $765,000 | -7.0% | 73,238 | +12.0% | 0.00% | – |
Q2 2022 | $823,000 | +45.7% | 65,362 | +25.5% | 0.00% | – |
Q1 2022 | $565,000 | -44.5% | 52,098 | -28.0% | 0.00% | – |
Q4 2021 | $1,018,000 | +22.4% | 72,329 | +67.0% | 0.00% | – |
Q3 2021 | $832,000 | +49.9% | 43,315 | -23.2% | 0.00% | – |
Q2 2021 | $555,000 | -24.3% | 56,388 | -24.4% | 0.00% | – |
Q1 2021 | $733,000 | +66.2% | 74,539 | -24.7% | 0.00% | – |
Q4 2020 | $441,000 | +3.3% | 99,005 | +0.2% | 0.00% | – |
Q3 2020 | $427,000 | -55.5% | 98,805 | -8.7% | 0.00% | – |
Q2 2020 | $960,000 | +65.5% | 108,221 | -34.2% | 0.00% | – |
Q1 2020 | $580,000 | -38.2% | 164,353 | +0.3% | 0.00% | – |
Q4 2019 | $938,000 | +45.4% | 163,927 | -9.2% | 0.00% | – |
Q3 2019 | $645,000 | +277.2% | 180,483 | +320.5% | 0.00% | – |
Q2 2019 | $171,000 | -45.4% | 42,916 | +0.2% | 0.00% | – |
Q1 2019 | $313,000 | -19.7% | 42,816 | +0.5% | 0.00% | – |
Q4 2018 | $390,000 | -52.3% | 42,616 | -35.3% | 0.00% | – |
Q3 2018 | $817,000 | -19.6% | 65,903 | -1.1% | 0.00% | – |
Q2 2018 | $1,016,000 | +28.8% | 66,634 | +67.6% | 0.00% | – |
Q1 2018 | $789,000 | +30.0% | 39,759 | +22.6% | 0.00% | – |
Q4 2017 | $607,000 | -13.0% | 32,440 | -0.1% | 0.00% | – |
Q3 2017 | $698,000 | +100.6% | 32,468 | -10.1% | 0.00% | – |
Q2 2017 | $348,000 | +61.1% | 36,106 | -0.8% | 0.00% | – |
Q1 2017 | $216,000 | +50.0% | 36,380 | 0.0% | 0.00% | – |
Q4 2016 | $144,000 | -62.3% | 36,380 | 0.0% | 0.00% | – |
Q3 2016 | $382,000 | +1.6% | 36,380 | +41.1% | 0.00% | – |
Q2 2016 | $376,000 | -6.9% | 25,780 | +22.9% | 0.00% | – |
Q1 2016 | $404,000 | -20.3% | 20,980 | 0.0% | 0.00% | – |
Q4 2015 | $507,000 | +1.4% | 20,980 | +2.9% | 0.00% | – |
Q3 2015 | $500,000 | +4.8% | 20,380 | 0.0% | 0.00% | – |
Q2 2015 | $477,000 | +4.4% | 20,380 | 0.0% | 0.00% | – |
Q1 2015 | $457,000 | +31.7% | 20,380 | -1.0% | 0.00% | – |
Q4 2014 | $347,000 | – | 20,580 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |